Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Acura Pharmaceuticals
(OTCEM:ACUR)
Intraday
$0.01
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.01
0
[0.00%]
At close: Apr 19
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Acura Pharmaceuticals Stock (OTC:ACUR)
Acura Pharmaceuticals Stock (OTC: ACUR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 14, 2021
Acura Pharmaceuticals Granted U.S. Patent #11,197,837 'Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse'
Charles Gross
-
Dec 14, 2021, 9:31AM
Monday, February 10, 2020
Acura Pharmaceuticals Q2 EPS $(0.15) Down From $(0.06) YoY, Sales $46K May Not Compare To $92K Estimate
Benzinga Newsdesk
-
Feb 10, 2020, 4:31PM
Tuesday, November 05, 2019
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
-
Nov 5, 2019, 11:12AM
Friday, September 06, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
-
Sep 6, 2019, 12:23PM
Wednesday, July 03, 2019
The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief
Shanthi Rexaline
-
Jul 3, 2019, 7:31AM
Wednesday, January 03, 2018
Form 4 Filing Out Late Tuesday Shows Acura Pharma Former 10% Owner Claudius LLC Sold ~2.196M Shares At $0.10 As Part Of Stock Purchase Agreement
Benzinga
-
Jan 3, 2018, 8:54AM
Monday, August 14, 2017
Acura Pharmaceuticals Reports Q2 EPS $(0.18) vs $(0.28) In Same Period Last Year, Sales $92K vs $340K Est.
Benzinga
-
Aug 14, 2017, 4:20PM
Thursday, May 18, 2017
Acura Pharma Reports Initiation of Second Clinical Study on LTX-04
Benzinga
-
May 18, 2017, 4:14PM
Thursday, February 16, 2017
22 Biggest Mid-Day Losers For Thursday
Benzinga
-
Feb 16, 2017, 12:54PM
Wednesday, February 08, 2017
20 Biggest Mid-Day Losers For Wednesday
Benzinga
-
Feb 8, 2017, 1:09PM
Tuesday, February 07, 2017
Acura Pharmaceuticals Shares Up ~160 At $1.29/Share
Benzinga
-
Feb 7, 2017, 3:40PM
Friday, February 03, 2017
S-1 from Acura Pharma Shows Registration for $5M Common Stock, Warrants Offering
Benzinga
-
Feb 3, 2017, 5:18PM
Wednesday, January 04, 2017
A Peek Into The Markets: U.S. Stock Futures Rise; FOMC Minutes In Focus
Benzinga
-
Jan 4, 2017, 7:51AM
Keep an Eye on These 7 Stocks for January 4, 2017
Benzinga
-
Jan 4, 2017, 5:17AM
Tuesday, January 03, 2017
Acura Pharma Shares to Resume Trade at 4:45 p.m. EST
Benzinga
-
Jan 3, 2017, 4:20PM
UPDATE: Acura Pharma Shares Were Halted at 4:10:02 p.m. EST Ahead of News Co. Exploring Strategic Alternatives
Benzinga
-
Jan 3, 2017, 4:15PM
Acura Pharma Announces Exploration of Strategic Alternatives
Benzinga
-
Jan 3, 2017, 4:15PM
Wednesday, December 14, 2016
Acura Pharmaceutical Receives FDA Advice Identifying Longer Term Studies Needed For Submission of NDA For LTX-04
Benzinga
-
Dec 14, 2016, 4:18PM
Friday, December 09, 2016
Acura Pharma Shares Recently Spike Higher in Price, Volume, Now Up ~15%
Benzinga
-
Dec 9, 2016, 10:29AM
Monday, November 14, 2016
Acura Pharmaceuticals Reports Q3 EPS $(0.75) vs. Est. $(0.27)
Benzinga
-
Nov 14, 2016, 4:16PM
Tuesday, October 18, 2016
KemPharm Announces Aversion Licensed to Acura Pharma
Benzinga
-
Oct 18, 2016, 6:35AM
Monday, September 26, 2016
Acura Pharmaceuticals Spikes to High of $1.70 on Volume
Benzinga
-
Sep 26, 2016, 3:23PM
Monday, August 08, 2016
Acura Pharma Reports Q2 EPS $(0.28), Inline, Sales $257K vs $200K Est.
Benzinga
-
Aug 8, 2016, 4:52PM
Wednesday, June 08, 2016
Acura Pharma Reports LIMITX Technology Successfully Confirms Oral Abuse Deterrence Capabilities
Benzinga
-
Jun 8, 2016, 4:17PM
Wednesday, May 18, 2016
Worst Performing Industries For May 18, 2016
Benzinga
-
May 18, 2016, 11:26AM
Monday, May 02, 2016
Acura Pharmaceuticals Reports Q1 EPS $(0.28) vs. Est. $(0.26)
Benzinga
-
May 2, 2016, 4:25PM
Tuesday, April 26, 2016
Acura Pharmaceuticals Receives Second U.S. Patent for Novel Limitx Abuse Deterrent Technology
Benzinga
-
Apr 26, 2016, 4:47PM
Wednesday, April 13, 2016
Acura Pharmaceutical's LimitxTechnology Successfully Shows Oral Abuse Deterrence
Benzinga
-
Apr 13, 2016, 4:12PM
Tuesday, April 12, 2016
Acura Pharma's LTX-04 Receives FDA Fast Track
Benzinga
-
Apr 12, 2016, 4:15PM
Friday, March 11, 2016
Benzinga's Top Initiations
Benzinga
-
Mar 11, 2016, 9:37AM
Roth Capital Initiates Coverage on Acura Pharmaceuticals at Buy, Announces $6.00 PT
Benzinga
-
Mar 11, 2016, 7:40AM
Monday, February 29, 2016
Acura Pharma Reports Q4 EPS $(0.08) Vs Est $(0.03), Sales $2.679M Vs Est $2.70M
Benzinga
-
Feb 29, 2016, 4:32PM
Monday, February 01, 2016
Acura Pharma Reports Clincal Testing On LTX-04 To Begin Q1 2016
Benzinga
-
Feb 1, 2016, 4:10PM
Thursday, December 17, 2015
Acura Pharma Provides Updatye On Lumitx
Benzinga
-
Dec 17, 2015, 4:25PM
Wednesday, December 16, 2015
Stocks Hitting 52-Week Lows
Benzinga
-
Dec 16, 2015, 10:15AM
Wednesday, November 04, 2015
Acura Pharmaceuticals Reports Q3 EPS $(0.23) vs. Est. Breakeven, Rev. $210K vs. Est. $3.1M
Benzinga
-
Nov 4, 2015, 5:32PM
Monday, October 12, 2015
Aura Announces $2.5M Milestone Payment From Egalet
Benzinga
-
Oct 12, 2015, 6:30AM
Wednesday, September 09, 2015
Acura Pharma Announces Co. Egalet Have Commercially Launched US OXAYDO Tablets
Benzinga
-
Sep 9, 2015, 4:17PM
Monday, August 24, 2015
Acura Pharmaceuticals Reports 1-For-5 Reverse Stock Split
Benzinga
-
Aug 24, 2015, 4:15PM
Thursday, August 20, 2015
Top Performing Industries For August 20, 2015
Benzinga
-
Aug 20, 2015, 10:43AM
Tuesday, August 04, 2015
Worst Performing Industries For August 4, 2015
Benzinga
-
Aug 4, 2015, 11:09AM
Monday, August 03, 2015
Acura Pharma Reports Q2 Loss of $0.05/Share vs Loss of $0.02/Share Est., Sales $300K
Benzinga
-
Aug 3, 2015, 4:32PM
Thursday, July 09, 2015
Shares of Acura Pharma Edge to Session Highs Following 13G Filing from Sabby Mgmt Showing 7.9% Stake
Benzinga
-
Jul 9, 2015, 3:13PM
Wednesday, July 01, 2015
Acura Pharma Announces Will Raise ~$7.6M from Insititutional Healthcare Investors: 9.790M Shares at $0.78/Share
Benzinga
-
Jul 1, 2015, 6:17AM
Monday, June 29, 2015
Top Performing Industries For June 29, 2015
Benzinga
-
Jun 29, 2015, 10:56AM
Monday, May 04, 2015
Acura Pharma Reports Q1 EPS $0.03 vs. Est. $(0.01), Rev. $5.357M vs. Est. $7.6M
Benzinga
-
May 4, 2015, 4:16PM
Thursday, April 09, 2015
Acura Pharmaceuticals to Develop Abuse Deterrent Hydrocodone With Acetaminophen Tablets With Limitx Technology
Benzinga
-
Apr 9, 2015, 4:17PM
Monday, March 23, 2015
Acura Pharmaceuticals Reports Successful Topline Results from Nexafed Extended-Release Clinical Study; Intends to Request Pre-Ind Meeting With FDA to Review Study Data, Discuss Complete Development Program
Benzinga
-
Mar 23, 2015, 6:07AM
Monday, March 02, 2015
Acura Pharma Reports Q4 EPS $(0.06)
Benzinga
-
Mar 2, 2015, 4:31PM
Friday, February 27, 2015
MLV & Co Upgrades Acura Pharmaceuticals To Buy
Benzinga
-
Feb 27, 2015, 8:59AM
Show more